Photo = Pinpoint News DB
[핀포인트뉴스 이경선 기자] Hyundai Bio stock price is fluctuating.
According to the Korea Exchange, trading closed at 21,650 won on the 1st day, up 3.10% from the previous trading day.
The stock price is trying to break out of its long-term range.
The rapid increase in dengue fever patients and deaths in the Americas, including the United States, is believed to be giving a boost to stock prices.
Hyundai Bio is attracting investor attention by developing “Zefty”, an antiviral drug against dengue fever.
Previous trading day Monkeypox Related stocks Genematrix Access Bio Caspion Palmgen Science Hyundai Bio Access Bio Seegene Bioneer Green Cross MS Pharmicell Green Cross Holdings Boditech Med Caspion Labgenomics Genolution HK Innoen Blade Ent HK Innoen Caspion Oh Sangjael Mycobiomed HK Most of Innoen Green Cross Holdings , Bodytech Med , and Osangjael has fluctuated significantly.
GeneMatrix engages in the development and sale of medical devices that collectively diagnose diseases using its molecular diagnostic technology.
It is divided into the Molecular Diagnostics Business Division and the In Vitro Diagnostics Business Division and includes products such as NeoPlex STI, OmniPlex-HPV, Rapid Biochemistry & Medical Equipment, and LUCICA GA.
#Hyundai #Bio #stock #price #takes #hit.. #Dengue #fever #infection #cases #deaths #rise #rapidly #Americas
